Quantcast
Last updated on April 16, 2014 at 13:58 EDT

Latest Prodrugs Stories

2013-02-26 08:29:27

DENVER, Feb. 26, 2013 /PRNewswire/ -- The national debate over opioid use and the rise in overdoses continued with a hearing before the FDA this month and in January the New York Mayor put limits on how its hospitals fill opioid prescriptions. (Logo: http://photos.prnewswire.com/prnh/20130226/LA66164LOGO) The focus of the FDA's dedicated task force is to reduce the misuse and abuse of opioids. Their multi-pronged approach includes improving labeling, packaging, and storage along with...

2013-02-25 08:30:29

PITTSBURGH, Feb. 25, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has begun shipping Fenofibrate Capsules USP, 43 mg and 130 mg. This product is the generic version of Lupin Atlantis Holdings, S.A.'s Antara(®) Capsules, which are indicated as an adjunct to diet to reduce elevated LDL-C, Total-C, triglycerides, and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia and to reduce...

2013-02-17 23:00:35

1,4-Butanediol Market report estimates the market size of 1,4-butanediol industry for major applications such as tetrahydrofuran, polybutylene terphthalate, gamma butyrolactone, polyurethane and others. (PRWEB) February 17, 2013 The report “1,4-butanediol Market By Technology (Reppe Process, Davy process, Butadiene Process, Propylene Oxide Process & Others), Applications, & Geography: Global Industry Trends & Forecasts to 2017”, published by MarketsandMarkets,...

2013-02-05 00:21:32

PARIS and TARRYTOWN, N.Y., Feb. 5, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Commission (EC) has granted marketing authorization in the European Union for ZALTRAP 25mg/ml concentrate for solution for infusion in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) chemotherapy in adults with metastatic colorectal cancer (mCRC) that is resistant to or has progressed after an...

2013-02-04 08:26:48

SANDY, Utah, Feb. 4, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals, Inc. (the "Company") OTC symbol (RAFA) announced that it has received the general license for pharmaceutical products and has started the manufacturing of 3 new products. The general license was one of the final steps required to open the new plant in Terbuniy. The Company is now in operation and is expected to rapidly increase to 100% capacity of the Terbiniy facility with the addition of government contracts provided by...

2013-01-25 12:25:43

NEW BRUNSWICK, N.J., Jan. 25, 2013 /PRNewswire-USNewswire/ -- Parkinson's disease affects one million people in the United States and seven million worldwide. While L-Dopa is effective in treating the disease symptoms, the vast majority of patients taking it chronically eventually develop L-Dopa Induced Dyskinesia (LID), abnormal involuntary movements that can be disabling. A new company, MentiNova, Inc., is exploring an oral medication that could reduce these uncontrollable, often chaotic...

2013-01-23 12:25:51

Only 1 in 5 parents say they are very concerned about children, teens misusing narcotics, according to U-M's National Poll on Children's Health ANN ARBOR, Mich., Jan. 23, 2013 /PRNewswire-USNewswire/ -- Despite data on rising rates of abuse and overdoses of narcotic pain medicines across all age groups, in a new poll from the University of Michigan, most parents said they are not very concerned about misuse of these medicines by children and teens. In addition, parent support was...

2012-12-11 08:27:39

WOODCLIFF LAKE, N.J., Dec. 11, 2012 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) determined that Eisai has met the FDA's Written Request requirements for pediatric exclusivity for ACIPHEX(® )(rabreprazole sodium). As a result, Eisai has now gained an additional 6 months of United States market exclusivity for ACIPHEX, which will expire on November 8, 2013. (Logo: http://photos.prnewswire.com/prnh/20120413/MM87168LOGO ) The granting of...

2012-12-10 12:23:39

Results show that the drug could extend progression-free survival Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor. Mesupron® is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a recent phase II clinical...

Tamoxifen Treatment Could Be Extended To Ten Years
2012-12-06 06:46:11

Connie K. Ho for redOrbit.com — Your Universe Online Researchers from the University of Oxford recently revealed a study which showed that prolonged use of tamoxifen could help breast cancer from returning. Tamoxifen has been used in the past as daily treatment for female patients with breast cancer in remission. The study could impact the current recommendations for the treatment, which is five years for female patients. The findings of the study were recently revealed at the...